Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Sterling

Showing results (31-40 of 330) with videos related to

Pageof 33
Sort By:
AIDS Research and Human Retroviruses|December 28, 2007
HIV in the workplace in Botswana: incidence, prevalence, and disease severityElisabeth D Riviello, Timothy R Sterling, Bryan Shepherd, et al.
American Journal of Respiratory and Critical Care Medicine|May 20, 2006
Lack of weight gain and relapse risk in a large tuberculosis treatment trialAwal Khan, Timothy R Sterling, Randall Reves, et al.
Tuberculosis (Edinburgh, Scotland)|November 27, 2013
25-Hydroxyvitamin D levels after recovery from tuberculosis: insights into pathogenesisMoises A Huaman, Timothy R Sterling, Bryan E Shepherd, et al.
Clinical and Vaccine Immunology : CVI|November 1, 2011
Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosisAlexandre S de Almeida, Christina T Fiske, Timothy R Sterling, et al.
Tropical Diseases, Travel Medicine and Vaccines|February 3, 2016
Tuberculosis and Cardiovascular Disease: Linking the EpidemicsMoises A Huaman, David Henson, Eduardo Ticona, et al.
AIDS Research and Human Retroviruses|January 28, 2006
Serum albumin as a prognostic indicator for HIV disease progressionShruti H Mehta, Jacquie Astemborski, Timothy R Sterling, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2005
Prescribing of contraindicated protease inhibitor and statin combinations among HIV-infected personsTodd Hulgan, Timothy R Sterling, Jim Daugherty, et al.
American Journal of Respiratory and Critical Care Medicine|January 21, 2006
The scope and impact of treatment of latent tuberculosis infection in the United States and CanadaTimothy R Sterling, James Bethel, Stefan Goldberg, et al.
Journal of Clinical Epidemiology|December 26, 2008
Cross-cohort heterogeneity encountered while validating a model for HIV disease progression among antiretroviral initiatorsBryan E Shepherd, Timothy R Sterling, Richard D Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2002
Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosisKelly E Dooley, Jonathan Golub, Fernando S Goes, et al.
Pageof 33

Showing results (31-40 of 330) with videos related to

Sort By:
Pageof 33
AIDS Research and Human Retroviruses|December 28, 2007
HIV in the workplace in Botswana: incidence, prevalence, and disease severityElisabeth D Riviello, Timothy R Sterling, Bryan Shepherd, et al.
American Journal of Respiratory and Critical Care Medicine|May 20, 2006
Lack of weight gain and relapse risk in a large tuberculosis treatment trialAwal Khan, Timothy R Sterling, Randall Reves, et al.
Tuberculosis (Edinburgh, Scotland)|November 27, 2013
25-Hydroxyvitamin D levels after recovery from tuberculosis: insights into pathogenesisMoises A Huaman, Timothy R Sterling, Bryan E Shepherd, et al.
Clinical and Vaccine Immunology : CVI|November 1, 2011
Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosisAlexandre S de Almeida, Christina T Fiske, Timothy R Sterling, et al.
Tropical Diseases, Travel Medicine and Vaccines|February 3, 2016
Tuberculosis and Cardiovascular Disease: Linking the EpidemicsMoises A Huaman, David Henson, Eduardo Ticona, et al.
AIDS Research and Human Retroviruses|January 28, 2006
Serum albumin as a prognostic indicator for HIV disease progressionShruti H Mehta, Jacquie Astemborski, Timothy R Sterling, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2005
Prescribing of contraindicated protease inhibitor and statin combinations among HIV-infected personsTodd Hulgan, Timothy R Sterling, Jim Daugherty, et al.
American Journal of Respiratory and Critical Care Medicine|January 21, 2006
The scope and impact of treatment of latent tuberculosis infection in the United States and CanadaTimothy R Sterling, James Bethel, Stefan Goldberg, et al.
Journal of Clinical Epidemiology|December 26, 2008
Cross-cohort heterogeneity encountered while validating a model for HIV disease progression among antiretroviral initiatorsBryan E Shepherd, Timothy R Sterling, Richard D Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2002
Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosisKelly E Dooley, Jonathan Golub, Fernando S Goes, et al.
Pageof 33